Stock On High Alert

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Walmart+ Membership Sees Remarkable Growth Walmart+ has reached an impressive milestone, experiencing substantial growth in its membership recently. A survey conducted by a well-known financial services firm revealed that Walmart+ now boasts around 25.9 million members, marking a notable increase from previous months. This uptick illustrates a clear shift as consumers...

A Tangled Web of Allegations There's nothing quite like waking up to the news that a company you might've bet on is swimming in legal hot water. And folks, that's the scene we’ve got here with Veritone, Inc. Under siege, the company—ticker VERI if you're peeping the NASDAQ—is dealing with a class action alleging violations of the Securities Exchange Act of 1934....

Canopy Growth Marks Success at Annual General Meeting Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) has shared the outcomes from its recent annual general meeting of shareholders. This gathering offered a platform for stakeholders to discuss and approve important decisions for the company. Key Matters Approved Every item put forth for shareholder consideration...

Palantir Technologies Inc Reaches New Peaks Palantir Technologies Inc (NASDAQ: PLTR) has recently experienced a thrilling surge, reaching an all-time high on a Wednesday morning. This impressive uptick has been propelled by a remarkable gain of over 150% in the stock value this year alone. Investors are energized by a series of advantageous contracts and endorsements from...

CIBC Expands CDR Offerings with New Launch on Canadian Exchange Cboe Canada Inc. proudly reintroduces CIBC, who has recently added ten new Canadian Depositary Receipts (CDRs) to its platform. This expansion significantly boosts CIBC’s total offerings to a robust 80 CDR tickers, which includes some of the most recognized public companies from the U.S. and German markets....